These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Loss of Function in Dopamine D3 Receptor Attenuates Left Ventricular Cardiac Fibroblast Migration and Proliferation Kisling A; Byrne S; Parekh RU; Melit-Thomas D; de Castro Brás LE; Lust RM; Clemens S; Sriramula S; Katwa LC Front Cardiovasc Med; 2021; 8():732282. PubMed ID: 34708087 [TBL] [Abstract][Full Text] [Related]
24. Dose-response analysis of locomotor activity and stereotypy in dopamine D3 receptor mutant mice following acute amphetamine. McNamara RK; Logue A; Stanford K; Xu M; Zhang J; Richtand NM Synapse; 2006 Oct; 60(5):399-405. PubMed ID: 16856172 [TBL] [Abstract][Full Text] [Related]
25. Involvement of D1/D2 dopamine receptors within the nucleus accumbens and ventral tegmental area in the development of sensitization to antinociceptive effect of morphine. Reisi Z; Bani-Ardalan M; Zarepour L; Haghparast A Pharmacol Biochem Behav; 2014 Mar; 118():16-21. PubMed ID: 24418216 [TBL] [Abstract][Full Text] [Related]
26. Effects of morphine and endomorphins on the polysynaptic reflex in the isolated rat spinal cord. Tao PL; Lai YS; Chow LH; Huang EY Naunyn Schmiedebergs Arch Pharmacol; 2005 Jan; 371(1):72-80. PubMed ID: 15726451 [TBL] [Abstract][Full Text] [Related]
27. Dopaminergic denervation switches dopamine D3 receptor signaling and disrupts its Ca(2+) dependent modulation by CaMKII and calmodulin in striatonigral projections of the rat. Avalos-Fuentes A; Albarrán-Bravo S; Loya-Lopéz S; Cortés H; Recillas-Morales S; Magaña JJ; Paz-Bermúdez F; Rangel-Barajas C; Aceves J; Erlij D; Florán B Neurobiol Dis; 2015 Feb; 74():336-46. PubMed ID: 25517101 [TBL] [Abstract][Full Text] [Related]
28. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Capasso A; Sorrentino L Br J Pharmacol; 1997 Mar; 120(6):1001-6. PubMed ID: 9134209 [TBL] [Abstract][Full Text] [Related]
29. Different roles of dopamine receptor subtypes in footshock stress-induced enhancement of morphine conditioned place preference. Dai Z; Kang L; Wang L; Ma L Neurosci Lett; 2006 Nov; 409(1):52-6. PubMed ID: 17000048 [TBL] [Abstract][Full Text] [Related]
30. Dopamine D3 receptor knock-out mice display deficits in locomotor sensitization after chronic morphine administration. Li T; Hou Y; Yan CX; Chen T; Zhao Y; Li SB Neurosci Lett; 2010 Nov; 485(3):256-60. PubMed ID: 20849922 [TBL] [Abstract][Full Text] [Related]
31. Targeting the dopamine D3 receptor: an overview of drug design strategies. Cortés A; Moreno E; Rodríguez-Ruiz M; Canela EI; Casadó V Expert Opin Drug Discov; 2016 Jul; 11(7):641-64. PubMed ID: 27135354 [TBL] [Abstract][Full Text] [Related]
32. Modification of brain and spinal cord dopamine D1 receptors labeled with [3H]SCH 23390 after morphine withdrawal from tolerant and physically dependent rats. Bhargava HN; Gulati A J Pharmacol Exp Ther; 1990 Mar; 252(3):901-7. PubMed ID: 2138669 [TBL] [Abstract][Full Text] [Related]
33. Current drug treatments targeting dopamine D3 receptor. Leggio GM; Bucolo C; Platania CB; Salomone S; Drago F Pharmacol Ther; 2016 Sep; 165():164-77. PubMed ID: 27343365 [TBL] [Abstract][Full Text] [Related]
34. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors. Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171 [TBL] [Abstract][Full Text] [Related]
35. Dopamine D3 Receptor in Parkinson Disease: A Prognosis Biomarker and an Intervention Target. Xu J Curr Top Behav Neurosci; 2023; 60():89-107. PubMed ID: 35711029 [TBL] [Abstract][Full Text] [Related]
36. Time-resolved FRET binding assay to investigate hetero-oligomer binding properties: proof of concept with dopamine D1/D3 heterodimer. Hounsou C; Margathe JF; Oueslati N; Belhocine A; Dupuis E; Thomas C; Mann A; Ilien B; Rognan D; Trinquet E; Hibert M; Pin JP; Bonnet D; Durroux T ACS Chem Biol; 2015 Feb; 10(2):466-74. PubMed ID: 25350273 [TBL] [Abstract][Full Text] [Related]
37. Prolonged treatment with pramipexole promotes physical interaction of striatal dopamine D3 autoreceptors with dopamine transporters to reduce dopamine uptake. Castro-Hernández J; Afonso-Oramas D; Cruz-Muros I; Salas-Hernández J; Barroso-Chinea P; Moratalla R; Millan MJ; González-Hernández T Neurobiol Dis; 2015 Feb; 74():325-35. PubMed ID: 25511804 [TBL] [Abstract][Full Text] [Related]
38. Effects of immobilization stress on emotional behaviors in dopamine D3 receptor knockout mice. Xing B; Liu P; Jiang WH; Liu F; Zhang H; Cao GF; Chen T; Dang YH Behav Brain Res; 2013 Apr; 243():261-6. PubMed ID: 23357086 [TBL] [Abstract][Full Text] [Related]
39. Brain stimulation and morphine reward deficits in dopamine D2 receptor-deficient mice. Elmer GI; Pieper JO; Levy J; Rubinstein M; Low MJ; Grandy DK; Wise RA Psychopharmacology (Berl); 2005 Oct; 182(1):33-44. PubMed ID: 16136297 [TBL] [Abstract][Full Text] [Related]
40. Role of D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptors in morphine tolerance and dependence in mice. Verma A; Kulkarni SK Eur Neuropsychopharmacol; 1995 Jun; 5(2):81-7. PubMed ID: 7549459 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]